Overview of Dr. Usha
Dr. Lydia Usha is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Loyola University Medical Center. She received her medical degree from St Petersburg State Pediatric Medicine Academy and has been in practice 35 years. Dr. Usha accepts several types of health insurance, listed below. She is one of 57 doctors at Rush University Medical Center and one of 347 doctors at Loyola University Medical Center who specialize in Oncology. She also speaks multiple languages, including Russian. She has more than 30 publications and over 500 citings.
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612Fax+1 312-942-3192
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
California Pacific Medical CenterResidency, Internal Medicine, 1993 - 1997
St Petersburg State Pediatric Medicine AcademyClass of 1982
Certifications & Licensure
CA State Medical License 1995 - Present
IL State Medical License 1997 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Start of enrollment: 2005 Jul 01
- Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2006 Nov 01
- Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh
Cardio-Oncology. 2024-02-06 - 1 citationsSoluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh
Cardio-Oncology. 2024-01-15 - 1 citationsImpact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.Jordan Lieberenz, Mia Levy, Rosalinda Alvarado, Shirlene Paul, Melody Cobleigh
Journal of the American College of Radiology. 2023-01-01
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Professional Memberships
- Member
Other Languages
- Russian
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPOGreat West PPO
Health Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
